-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ck/rwAmawtxv1NKppwRwg6dAmEBC70PEIWneozlyvxok89bQP8qqhAwbYc034uZn 6Efj+bV+KECXiUnFzSMNCA== 0001209191-09-019519.txt : 20090402 0001209191-09-019519.hdr.sgml : 20090402 20090402132840 ACCESSION NUMBER: 0001209191-09-019519 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090331 FILED AS OF DATE: 20090402 DATE AS OF CHANGE: 20090402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARVER DAVID L CENTRAL INDEX KEY: 0001448599 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51512 FILM NUMBER: 09726437 MAIL ADDRESS: STREET 1: 221 1ST STREET, #412 CITY: KIRKLAND STATE: WA ZIP: 98033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiac Science CORP CENTRAL INDEX KEY: 0001323115 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 943300396 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 425-402-2206 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: CSQ Holding CO DATE OF NAME CHANGE: 20050407 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2009-03-31 0 0001323115 Cardiac Science CORP CSCX 0001448599 MARVER DAVID L 3303 MONTE VILLA PARKWAY BOTHELL WA 98021 1 1 0 0 President & CEO Stock Options 3.01 2009-03-31 4 A 0 140000 0.00 A 2010-03-31 2019-03-31 Common Stock 140000 140000 D 25% of the shares vest 12 months after the Vesting Commencement Date and 1/36th of the remaining shares vest monthly thereafter for the next 36 months. /s/David L Marver Michael Matysik Attorney-in-fact 2009-04-02 EX-24.4_281589 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of David Marver and Michael Matysik signing singly, the undersigned's true and lawful attorney in fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Cardiac Science Corporation (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney in fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney in fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney in fact may approve in such attorney in fact's discretion. The undersigned hereby grants to each such attorney in fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney in fact, or such attorney in fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys in fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys in fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 26th day of March, 2009. Signature: David L Marver Print Name: David L Marver -----END PRIVACY-ENHANCED MESSAGE-----